Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Hauptverfasser: Shinya Takasaki (Verfasst von), Hisanobu Adachi (Verfasst von), Yoshihide Kawasaki (Verfasst von), Masafumi Kikuchi (Verfasst von), Akihiro Ito (Verfasst von), Nariyasu Mano (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...